نتائج البحث - "MTOR Inhibitors"

41

دورية أكاديمية

Exploiting the therapeutic potential of the PI3K-AKT-mTOR pathway in enriched populations of gynecologic malignancies

المؤلفون: Eskander, Ramez N, Tewari, Krishnansu S

المصدر: Expert Review of Clinical Pharmacology. 7(6)

مصطلحات موضوعية: Reproductive Medicine, Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Cervical Cancer, Uterine Cancer, Clinical Trials and Supportive Activities, Clinical Research, Cancer, Biotechnology, Rare Diseases, Animals, Antineoplastic Agents, Clinical Trials, Phase II as Topic, Drug Design, Female, Genital Neoplasms, Female, Humans, Neoplasm Recurrence, Local, Phosphoinositide-3 Kinase Inhibitors, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases, cervical cancer, clear cell ovarian cancer, endometrial cancer, mTOR inhibitors, PI3K/AKT/mTOR pathway, PTEN, Pharmacology and Pharmaceutical Sciences, Pharmacology & Pharmacy, Pharmacology and pharmaceutical sciences

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/01p8v6nvTest

View record in eScholarship

42

دورية

Researchers Submit Patent Application, "Methods Of Treating Cancer With An Mtor Inhibitor", for Approval (USPTO 20240100056).

المصدر: Pharma Business Week; 4/16/2024, p2018-2018, 1p

مصطلحات موضوعية: PATENT applications, MTOR inhibitors, RESEARCH personnel, COENZYMES

43

دورية

Patent Application Titled "Methods Of Treating Cancer With An Mtor Inhibitor" Published Online (USPTO 20240082249).

المصدر: Cancer Weekly; 4/2/2024, p1731-1731, 1p

مصطلحات موضوعية: PATENT applications, MTOR inhibitors, INTERNET publishing, COENZYMES

44

دورية

"Methods Of Treating Hematological Malignancy Using Nanoparticle Mtor Inhibitor Combination Therapy" in Patent Application Approval Process (USPTO 20240082224).

المصدر: Cancer Vaccine Week; 4/1/2024, p131-131, 1p

مصطلحات موضوعية: PATENT applications, MTOR inhibitors, HEMATOLOGIC malignancies, NANOPARTICLES, BLOOD proteins

45

دورية

Findings from University of Texas MD Anderson Cancer Center in the Area of Cholangiocarcinoma Described (Crispr Screening Identifies Bet and Mtor Inhibitor Synergy In Cholangiocarcinoma Through Serine Glycine One Carbon).

المصدر: Gene Therapy Weekly; 2024, p389-389, 1p

مصطلحات موضوعية: MTOR inhibitors, CHOLANGIOCARCINOMA, SERINE, MEDICAL screening, GLYCINE

46

دورية

Zhejiang University School of Medicine Researchers Focus on Liver Cancer (mTOR inhibitor reduces nontumour-related death in liver transplantation for hepatocellular carcinoma).

المصدر: Drug Week; 2024, p1382-1382, 1p

مصطلحات موضوعية: LIVER cancer, HEPATOCELLULAR carcinoma, LIVER transplantation, MTOR inhibitors, RESEARCH personnel, RAPAMYCIN

47

دورية

Researchers at Northwestern University Feinberg School of Medicine Release New Study Findings on Thyroid Cancer (Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly...).

المصدر: Immunotherapy Weekly; 2/15/2024, p956-956, 1p

مصطلحات موضوعية: MTOR inhibitors, IPILIMUMAB, NIVOLUMAB, THYROID cancer, RESEARCH personnel, DRUGS

الشركة/الكيان: NORTHWESTERN University (Evanston, Ill.)

48

دورية

Findings from Mazandaran University of Medical Sciences in the Area of Acute Myeloid Leukemia Reported (Glucose Metabolism In Acute Myeloid Leukemia Cell Line Is Regulated Via Combinational Pi3k/akt/mtor Pathway Inhibitors).

المصدر: Drug Week; 2/16/2024, p668-668, 1p

مصطلحات موضوعية: ACUTE myeloid leukemia, MYELOID cells, GLUCOSE metabolism, MTOR inhibitors, CELL lines, GLUCOSE transporters, PYRUVATES

49

دورية

"Methods Of Treating Colon Cancer Using Nanoparticle Mtor Inhibitor Combination Therapy" in Patent Application Approval Process (USPTO 20240009323).

المصدر: Women's Health Weekly; 2/2/2024, p1283-1283, 1p

مصطلحات موضوعية: MTOR inhibitors, EVEROLIMUS, PATENT applications, COLON cancer, NANOPARTICLES, VASCULAR endothelial growth factors

50

Brain-restricted mTOR inhibition with binary pharmacology

المؤلفون: Kevin Lou, Ziyang Zhang, Kevan M. Shokat, Xujun Luo, William A. Weiss, Qi-Wen Fan

المصدر: Nature, vol 609, iss 7928

مصطلحات موضوعية: Drug, General Science & Technology, media_common.quotation_subject, Central nervous system, Tacrolimus Binding Protein 1A, Pharmacology, Ligands, Rare Diseases, Drug Therapy, medicine, Humans, Adverse effect, PI3K/AKT/mTOR pathway, media_common, Cancer, Sirolimus, Multidisciplinary, Kinase, business.industry, TOR Serine-Threonine Kinases, Neurosciences, Brain, MTOR Inhibitors, Ligand (biochemistry), medicine.disease, Xenograft Model Antitumor Assays, Brain Disorders, Brain Cancer, medicine.anatomical_structure, FKBP, Orphan Drug, 5.1 Pharmaceuticals, Combination, Neurological, Drug Therapy, Combination, Development of treatments and therapeutic interventions, business, Glioblastoma

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d384cbe2d04023b9624254d84e3a1a69Test
https://doi.org/10.1038/s41586-022-05213-yTest

تنقيح النتائج